Introducing a paradigm shift in interventional cardiology that benefits all parties
PATIENT
Receive better care with a true bifurcated stent that increases safety and reduces procedure times
DOCTOR
Perform excellent placement and stent delivery using an intuitive system similar to existing linear stent techniques
HOSPITALS
Optimize cath lab utilization and increase revenue from bifurcation procedures as a result of shorter procedure times
INSURANCE COMPANIES
Take advantage of up to a 50% reduction in materials and reduced costs due to shorter procedure times
See the Advanced Bifurcation Systems® platform in action
The ABS® platform is protected by more than 36 issued and 12 pending patents and, in total, has 300 solid claims pending in various stages. It will become the “standard of care” in the $2.5 billion global bifurcations market.
Full Bifurcation Stent (MD-BI)
Provisional Bifurcation Stent (MD-P)
Be a ABS® investor
This is your opportunity to be part of an aggressive, global marketing strategy that will promote rapid penetration and sales. To join, simply fill out the form and one of our staff will get in touch with you.